GRI Bio prices $4.0M public offering of shares and warrants at $1.83/unit

GRI Bio, Inc.

Offering of 2,185,793 shares (or equivalents) plus Series C-1 and C-2 warrants at $1.83 per unit.
Gross proceeds ~$4.0M, net proceeds ~$3.2M after 7% placement agent fee and expenses.
Warrants exercisable at $1.83/share upon stockholder approval; C-1 expires 5 yrs, C-2 expires 18 months.
Proceeds allocated to product candidate development, working capital, and general corporate purposes.
H.C. Wainwright is exclusive placement agent; closing expected on or about June 28, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.